Advertisement
Screener

Bumble Inc. (BMBL) Spending and interest coverage

Bumble Inc. (BMBL) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 4.65%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months4.65%Share-based compensation / revenue. Period ending 2026-06-30.

$41.54M ÷ $893.24M × 100 ≈ 4.65%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue893.24M USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation41.54M USDShare-based Payment Arrangement, Noncash Expense
Operating income-558.84M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)$893.24M$41.54M$-558.84M(m)(m)4.65%(m)(m)
2026-03-31(m)$930.94M$37.87M$-785.17M(m)(m)4.07%(m)(m)
2025-12-31(m)$965.66M$31.19M$-805.78M(m)(m)3.23%(m)(m)
2025-09-30(m)$1.00B$35.57M$-193.07M(m)(m)3.55%(m)(m)
2025-06-30(m)$1.03B$34.12M$-1.09B(m)(m)3.31%(m)(m)
2025-03-31(m)$1.05B$30.36M$-704.61M(m)(m)2.89%(m)(m)
2024-12-31(m)$1.07B$26.25M$-700.47M(m)(m)2.45%(m)(m)
2024-09-30(m)$1.08B$32.95M$-744.30M(m)(m)3.04%(m)(m)
2024-06-30(m)$1.09B$44.32M$123.88M(m)(m)4.08%(m)(m)
2024-03-31(m)$1.08B$75.78M$93.10M(m)(m)7.04%(m)(m)
2023-12-31(m)$1.05B$104.34M$53.37M(m)(m)9.92%(m)(m)
2023-09-30(m)$1.02B$117.49M$-87.20M(m)(m)11.52%(m)(m)
2023-06-30(m)$976.95M$133.14M$-88.86M(m)(m)13.63%(m)(m)
2023-03-31(m)$936.42M$122.03M$-112.80M(m)(m)13.03%(m)(m)
2022-12-31(m)$903.50M$111.01M$-102.84M(m)(m)12.29%(m)(m)
2022-09-30(m)$873.67M$101.59M$40.01M(m)(m)11.63%(m)(m)
2022-06-30(m)$840.38M$88.17M$3.46M(m)(m)10.49%(m)(m)
2022-03-31(m)$806.15M$95.64M$-3.27M(m)(m)11.86%(m)(m)
2021-12-31(m)$765.66M$123.91M$-134.68M(m)(m)16.18%(m)(m)
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-01-28(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31(m)$488.94M$2.16M$93.25M(m)(m)0.44%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
System1, Inc. (SST)United States$0.287B-1.64
Health Catalyst, Inc. (HCAT)United States$0.132B-0.56
Eva Live Inc (GOAI)United States$0.083B
PodcastOne, Inc. (PODC)United States$0.068B-42.98
Professional Diversity Network, Inc. (IPDN)United States$0.060B
Teads Holding Co. (TEAD)United States$0.045B-0.14
Cardlytics, Inc. (CDLX)United States$0.020B-0.24
INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM)United States$0.016B-4.22
Global Interactive Technologies, Inc. (GITS)$0.008B
TaoWeave, Inc. (TWAV)United States$0.006B